Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 October 2021 | Story Xolisa Mnukwa

The University of the Free State (UFS) is currently developing a COVID-19 Regulations and Required Vaccination Policy that all students will have to adhere to in 2022. This policy is being developed to ensure a safe environment for all staff and students upon their return in 2022. 

The university is taking these measures to minimise the risk of exposing staff and students to infection and to enable a safe return to all three UFS campuses next year. However, the university will implement the policy in such a way that it will adequately accommodate individuals who are choosing not to get vaccinated for legitimate reasons.

In order to encourage our students to make the responsible choice by keeping themselves and others safe, the UFS Division of Student Affairs (DSA) is launching a COVID-19 Vaccination Drive that will take place from Monday, 25 October to Wednesday, 27 October 2021.

The programme is as follows:


Monday, 25 October 2021
When: 11:00-14:00
Where: outside Gate 5, UFS Bloemfontein Campus
What: Live performances by students, KovsieFM, KovsieTV, Vox Pops, free UFS branded T-shirts, and giveaways

Wednesday, 27 October 2021
When: 11:00-14:00
Where: Thakaneng Bridge
What: Live performances by local artists and students, KovsieFM, KovsieTV, Vox Pops, free UFS branded T-shirts, and giveaways

COVID-19 Vaccination panel discussion

The Vaccination Drive will conclude on Wednesday, 27 October 2021 with an online panel discussion titled: COVID Vaccination. Informed Youth. Informed Decisions. 
The discussion will start at 16:00 on MS Teams, and students are welcome to join us and ask for advice or clarification about the vaccine from our panel members. The link will be provided soon.

Facilitator: 
Dr Musa Mthombeni, Local TV personality

Panel members include:
Tshepo Moloi, Alumni and Economist representation business sector
Dr Musawenkosi Donia Saurombe, Youngest female PhD holder, lecturer and UFS Alumni
Jerry Thoka, ISRC President
Vusumzi Gqalane, SRC Policy and Transformation on the UFS Vaccination Policy
Asive Dlanjwa, South African Union of Students (SAUS) spokesperson
Victor Sekekete, Free State Cheetahs Rugby Player
Shaxe Khumalo, Entertainment Industry


For more information on the vaccination drive, contact Rethabile Motseki, motsekir@ufs.ac.za or Michelle Nothling at NothlingM@ufs.ac.za 

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept